Substantial evidence exists that patients with scleroderma have immune dysfunction and autoimmunity, and several studies support the use of immunosuppressive treatment in these patients. Nihtyanova et ...
The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported. At week 24, the least squares mean ...
If you have trouble breathing, your doctor may recommend a few tests to figure out what’s causing it. Some measure how much air you breathe in or out or how much oxygen is going from your lungs to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback